Cetuximab Monoclonal Antibody from United States
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is used in colorectal and head-and-neck cancer therapy. Imported in bulk, unmixed form without retail packaging, it falls under tariff item 3002.13.00 as an immunological product.
Duty Rate — United States → Canada
0%
Import Tips
• Maintain records showing the product is a single, unmixed substance to support the 3002.13.00 classification
• Ensure no retail packaging or dosing instructions are included in the shipment
• Check if a Clinical Trial Application or Drug Submission is needed for the intended use